Final lesion clinical/pathology diagnosis | No. | Percent % | |
---|---|---|---|
Group I: Benign lesions | 78 | 39% | |
a) Ground glass nodules | 26/0 | 26 | 13% |
b) Pre-fissural nodules | 17/0 | 17 | 8.5% |
c) Inflammatory nodules | 13/0 | 13 | 6.5% |
d) Follow-up static small nodules | 10/0 | 10 | 5% |
e) Fat/calcifications containing nodules | 12/0 | 12 | 6% |
Group II; Malignant lesions | 122 | 61% | |
a) Metastatic nodules | 19/78 | 87 | 43.5% |
b) Sequamus cell carcinoma | 0/19 | 19 | 9.5% |
c) Adeno-carcinoma | 0/7 | 7 | 3.5% |
d) Alveolar lung cancer | 0/6 | 6 | 3% |
e) Small cell carcinoma | 0/3 | 3 | 1.5% |
Total | 200 | 100% |